Published in Vaccine Weekly, January 19th, 2005
"Ulcerative colitis and Crohn disease, collectively termed inflammatory bowel diseases (IBD), are chronic inflammatory diseases of the intestine that afflict more than 4 million people worldwide. Intestinal inflammation is characterized by an abnormal mucosal immune response to normally harmless antigens in the gut flora. In Crohn disease, the pathogenic mucosal immune response is a typical T helper (Th1) type cell response, whereas ulcerative colitis is predominantly associated with a Th2 response," scientists...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.